Hemostemix Inc., a pioneering public clinical-stage company, has successfully secured $2.7 million in funding to advance its groundbreaking work in blood-derived cell therapies. Focused on addressing medical conditions with unmet treatment needs, Hemostemix is at the forefront of innovation in regenerative medicine, developing solutions that promise to enhance patient outcomes and quality of life. This recent capital infusion will bolster the company's ongoing clinical studies and accelerate the path to commercialization for its cutting-edge therapies, particularly in the areas of cardiovascular disease and other chronic inflammatory conditions. The funding will not only support the pivotal clinical trials required for the advancement of their flagship product but will also facilitate the expansion of their research efforts into new therapeutic applications. Hemostemix aims to leverage this investment to refine their proprietary technology and cultivate strategic partnerships that can help bring these revolutionary treatments to market. As the landscape of healthcare continues to evolve, Hemostemix is committed to transforming the standard of care for patients suffering from diseases that have been historically difficult to treat. For updates on their progress and to learn more about their innovative treatments, please visit www.hemostemix.com.
Breaking News: Hemostemix Inc. Secures $2.7 Million in Funding for Blood-Derived Cell Therapies
Recently funded 路 $2.7MBiotechnology
Get the full Hemostemix Inc. company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
